0 NASDAQ Companies - July 8, 2019Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar DepressionRead More
0 TSX Venture News - July 8, 2019James E. Wagner Cultivation Corporation Announces Health Canada Approval for the Sale of Cannabis OilsRead More
0 TSX Venture News - July 8, 2019Reliq Health Technologies, Inc. Announces Execution of Settlement AgreementRead More
0 NYSE Companies - July 8, 2019Inspire Medical Systems, Inc. Announces UnitedHealthcare Coverage for Inspire Therapy for the Treatment of Obstructive Sleep ApneaRead More
0 NYSE Companies - July 8, 2019Civeo Announces Contract Award in Australia with Expected Revenues of Approximately A$82 millionRead More
0 NASDAQ Companies - July 8, 2019Newly Published Nicotinamide Riboside Study Further Demonstrates Safety of Sustained Niagen Supplementation and Optimal Dosing LevelsRead More
0 NASDAQ Companies - July 8, 2019Fanhua Provides Update on its Share Buyback Program for the Week of July 1, 2019Read More
0 NASDAQ Companies - July 8, 2019LPL Financial Extends Its Commitment to Innovation and Data-Driven Solutions With Hiring of New EVPRead More
0 NASDAQ Companies - July 8, 2019Catalyst Biosciences Meets the Primary Endpoint of Reduction in Annualized Bleeding Rate in the Phase 2 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Patients with Hemophilia A or B with InhibitorsRead More
